A novel platform for cancer therapy using extracellular vesicles
Open Access
- 1 December 2015
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 95, 50-55
- https://doi.org/10.1016/j.addr.2015.10.002
Abstract
No abstract availableKeywords
Funding Information
- Grant-in-Aid for the third term of a comprehensive 10-year strategy for cancer control
- Ministry of Education, Culture, Sports, Science and Technology
- Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) fellows
- Grant-in-Aid for the Japan Science and Technology Agency (JST)
- Council for Science and Technology Policy
- Grant-in-Aid for the Japan Agency for Medical Research and Development (A-MED)
- Grant-in-Aid for Basic Science and Platform Technology Program for Innovative Biological Medicine
- Grant-in-Aid for a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct)
- Japanese Ministry of Education, Culture, Sports, Science and Technology
This publication has 62 references indexed in Scilit:
- Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell MetastasisJournal of Biological Chemistry, 2013
- As we wait: coping with an imperfect nomenclature for extracellular vesiclesJournal of Extracellular Vesicles, 2013
- Tumor-exosomes and leukocyte activation: an ambivalent crosstalkCell Communication and Signaling, 2012
- A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particlesVaccine, 2012
- Exosome-mediated delivery of siRNA in vitro and in vivoNature Protocols, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the BrainMolecular Therapy, 2011
- GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4+ T-independent CTL responsesVaccine, 2011
- Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/MacrophagesMolecular Therapy, 2011
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010